Add like
Add dislike
Add to saved papers

Isomeric Diruthenium Complexes of a Heterocyclic and Quinonoid Bridging Ligand: Valence and Spin Alternatives for the Metal/Ligand/Metal Arrangement.

Inorganic Chemistry 2016 December 6
5,7,12,14-Tetraazapentacene-6,13-quinone (L) reacts with 2 equiv of [Ru(acac)2 (CH3 CN)2 ] to form two linkage isomeric bis(chelate) compounds, [{RuII (acac)2 }2 (μ-L)], blue 1, with 5,6;12,13 coordination and violet 2 with 5,6;13,14 coordination. The linkage isomers could be separated, structurally characterized in crystals as rac diastereomers (ΔΔ/ΛΛ), and studied by voltammetry (CV, DPV), EPR, and UV-vis-NIR spectroelectrochemistry (meso-1, rac-2). DFT and TD-DFT calculations support the structural and spectroscopic results and suggest a slight energy preference (ΔE = 263 cm-1 ) for the rac-isomer 1 as compared to 2. Starting from the RuII -(μ-L0 )-RuII configurations of 1 and 2 with low-lying metal-to-ligand charge transfer (MLCT) absorptions, the compounds undergo two reversible one-electron oxidation steps with open-shell intermediates 1+ (Kc = 4 × 104 ) and 2+ (Kc = 6 × 105 ). Both monocations display metal-centered spin according to EPR, but the DFT-calculated spin densities suggest a RuIII (μ-L•- )RuIII three-spin situation with opposite spin density at the bridging ligand for the meso form of 1+ , estimated to lie 1887 cm-1 lower in energy than rac-1+ , which is calculated with a Class II mixed-valent situation RuIII -(μ-L0 )-RuII . A three-spin arrangement RuIII -(μ-L•- )-RuIII with negative spin density at one metal site is suggested by DFT for rac-2+ which is more stable by ΔE = 890 cm-1 than rac-1+ . Reduction of 1 or 2 (Kc = 107 -108 ) occurs mainly at the central bridging ligand with notable contributions (30%) from the metals in 1- and 2- . The mixed-valent RuIII (μ-L)RuII versus radical-bridged RuIII (μ-L•- )RuIII alternative is discussed comprehensively in comparison with related valence-ambiguous cases.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app